Melissa Glasner on Integration of Gene Therapy Into Hemophilia Care
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, reposted from on LinkedIn:
”Thank you very much Melissa Glasner for this great and important work and the possibility to collaborate, many thanks also to Miriam Giles and International Society on Thrombosis and Haemostasis (ISTH).”
Quoting Melissa Glasner‘s post:
”I am excited to share that our latest manuscript has been published in Therapeutic Advances in Hematology!
This work explores clinicians’ knowledge, perceptions, and readiness to integrate gene therapy into hemophilia care.
Many thanks to the ISTH for the opportunity to contribute to this important conversation!
Thank you Wolfgang Miesbach for the mentorship, writing support, and the important insights that made this manuscript possible.
Shout out to Miriam Giles for carrying this manuscript through the submission process – couldn’t have done it without you!”
Read the full article here.
Article: Gene therapy for hemophilia: results of ISTH global survey on current knowledge, attitudes, and preparedness of the hemophilia care team
Authors: Melissa Glasner, Wolfgang Miesbach
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 10, 2026, 16:12Balancing Thrombosis and Bleeding in Antiphospholipid Syndrome
-
Sep 10, 2026, 16:07Miguel Teran: Why ROTEM Will Redefine Major Bleeding Management
-
Sep 10, 2026, 16:04Isaac Okello: Where Skyline Meets Savannah – Quiet Moments at GASCDO in Nairobi
-
Sep 10, 2026, 15:58Joyisa Deb: How Immune Recognition Reshapes Clinical Practice
-
Sep 10, 2026, 15:56Alexsander Santiago: When Was Your ECMO Anticoagulation Target Last Challenged?
-
Sep 10, 2026, 15:51Christopher Bocquet: A Call for Feedback on the Proposed 13th Edition of Standards for Biotherapy Services
-
Sep 10, 2026, 15:45Amos Gitonga Mbaabu: GASCDO Conference in Nairobi – Translating Sickle Cell Innovations into Equitable Care
-
Sep 10, 2026, 15:36Majdouline El Moussaoui: What If AA Amyloidosis is the First Clue to an Undiagnosed Monogenic Autoinflammatory Disease?
-
Sep 10, 2026, 15:21Pathogenesis and Emerging Targeted Therapies in Myeloproliferative Neoplasms – NEJM Group